We demonstrated that the abnormal expression of CLDN2 in IBD patients was due to miR-195-5p downregulation, and an increased expression in colonic epithelial cells was able to restore normal levels of this protein [35]. This evidence concerns the gene CLDN2 and inflammatory bowel disease.